课题基金 / 基金详情

Transcriptional Dynamics of Neuronal Differentiation

Transcriptional Dynamics of Neuronal Differentiation
神经元分化的转录动力学
批准号:
6761810
负责人:
Anne Eliane CHIARAMELLO
金额:
$30.4万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2007-06-30

项目摘要

项目成果

Anne Eliane CHIARAMELLO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (From the Applicant's Abstract): The main objective of this project is to dissect the underlying mechanisms of the transcriptional network controlling neuronal differentiation, maintenance and survival. This application specifically focuses on the transcriptional dynamics controlled by the neuronal-specific basic Helix-Loop-Helix (bHLH) transcription factor Nexl/Math-2, which is a member of the NeuroD subfamily. Our studies suggest that Nex 1 is a key regulator of the neuronal differentiation program as its expression is important to the execution of the NGF-induced differentiation pathway. Its overexpression in PC12 cells induces neurite outgrowth and expression of the neuronal marker GAP-43 in an NGF-independent manner. Most importantly, our studies reveal the first evidence that Nex 1 prevents apoptosis of NGF-deprived PC12 cells. Thus, the bHLH Nex 1 may be a key factor linking terminal differentiation to maintenance and survival of differentiated neurons. To test our hypotheses and to elucidate the transcriptional functions of Nex1 during neuronal differentiation and survival, we plan to execute the experiments outlined in the three following aims. Our strategy will employ the rat pheochromocytoma cell line, PC 12, as it is a well-established system to study neuronal differentiation, maintenance, and survival. Aim I will focus on the Nex 1-modulated transcriptional pathways leading to terminal neuronal differentiation. Initially, we will generate a double stable Nex 1 inducible PC 12 cell line that will permit the manipulation of both the timing and levels of Nex I expression. We will determine the extent of neuronal differentiation by assessing the level of neuronal markers using a combination of western blot and immunocytochemistry. Finally, we will perform a dynamic gene profiling at different stages of Nex1-induced differentiation by differential display and cDNA expression microarray. Aim II will address the molecular mechanisms by which Nex1 promotes neuronal survival. We will measure the expression of anti-apoptotic and pro-apoptotic genes by RT-PCR, as well as the temporal expression of neuronal markers, using our stable cell lines. Finally, aim III will explore the transcriptional mechanisms controlling Nex1 expression in the NGF-induced differentiation pathway, using a combination of DNase I footprinting, EMSA, and CAT assay analyses. The fact that Nex 1 exhibits neuroprotective properties makes it a promising target to enhance neuronal survival and design novel therapeutical approaches to treat neurodegenerative diseases, age-related neuronal disorders, and CNS injuries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
  • 批准号:
    10702207
  • 项目类别:
  • 资助金额:
    $95.71万
  • 财政年份:
    2021
  • 负责人:
    Anne Eliane CHIARAMELLO
  • 依托单位:
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
  • 批准号:
    10439890
  • 项目类别:
  • 资助金额:
    $55.7万
  • 财政年份:
    2021
  • 负责人:
    Anne Eliane CHIARAMELLO
  • 依托单位:
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
  • 批准号:
    10301261
  • 项目类别:
  • 资助金额:
    $57.48万
  • 财政年份:
    2021
  • 负责人:
    Anne Eliane CHIARAMELLO
  • 依托单位:
A Pharmaco-Epigenomic Intervention for the Mitochondrial Disorder MELAS
  • 批准号:
    8891656
  • 项目类别:
  • 资助金额:
    $40.84万
  • 财政年份:
    2015
  • 负责人:
    Anne Eliane CHIARAMELLO
  • 依托单位:
海外基金